[HTML][HTML] Inhibiting Endocannabinoid hydrolysis as emerging analgesic strategy targeting a spectrum of ion channels implicated in migraine pain

A Della Pietra, J Savinainen, R Giniatullin - International Journal of …, 2022 - mdpi.com
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

[PDF][PDF] Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen, R Giniatullin - Int. J. Mol. Sci, 2022 - getbrainbody.com
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

A Della Pietra, J Savinainen… - International Journal of …, 2022 - search.ebscohost.com
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen, R Giniatullin - 2022 - agris.fao.org
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

[PDF][PDF] Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen, R Giniatullin - Int. J. Mol. Sci, 2022 - pdfs.semanticscholar.org
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

[PDF][PDF] Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen, R Giniatullin - Int. J. Mol. Sci, 2022 - researchgate.net
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen… - International Journal of …, 2022 - search.proquest.com
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

A Della Pietra, J Savinainen… - International Journal of …, 2022 - europepmc.org
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen… - International journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …

[HTML][HTML] Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

A Della Pietra, J Savinainen… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Migraine is a disabling neurovascular disorder characterized by severe pain with still limited
efficient treatments. Endocannabinoids, the endogenous painkillers, emerged, alternative to …